B2 (BSquaredNetwork) fluctuates 55.7% in 24 hours: surge in trading volume and futures price spike drive movement
Bitget Pulse2026/04/28 01:19Volatility Brief
In the past 24 hours, B2's price rebounded from a low of $0.41476 to a high of $0.66305 before retracing, currently quoted at $0.51841, with a price swing of 55.7% (some sources report 59.9%). The 24-hour trading volume was approximately $15.7486 million, significantly larger than usual.
Analysis of Abnormal Movements
- Intense price fluctuations accompanied by abnormal trading volume spikes, with buy/sell volume reaching 3-7 times usual levels, suspected to be liquidity sweeps or stop-loss hunting.
- Binance futures experienced multiple price spikes (e.g., +5.5% to $0.4945, +3.03% to $0.5481), with trading volumes reaching 145,000 to 239,000 USDT.
No official announcements, large on-chain whale transfers, or major news events were reported within 24 hours. The community confirmed “no major headlines, pure price action.”
Market Views and Outlook
The prevailing sentiment in the community is cautious. Traders view the volatility as ‘stop-loss hunting or smart money distribution/accumulation.’ Short-term outlook remains bearish unless the $0.5650 support is regained; otherwise, the price may further decline to $0.4882-$0.4302. If a rebound is confirmed (e.g., double bottom or engulfing pattern), targets are $0.6175-$0.6482. Risk warning: High leverage is susceptible to liquidation cascades. It is recommended to re-enter only after structural confirmation.
Note: This analysis is automatically generated by AI based on public data and on-chain monitoring, and is for informational purposes only.Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
GSK (GSK.US), Inovio (INO.US), and Agios (AGIO.US) cluster for review, US innovative drugs welcome FDA approval window
The FDA will intensively decide on several new drugs in the next two weeks: GSK's functional cure therapy for hepatitis B, Inovio's rare disease therapy, Agios's new drug for sickle cell disease, and Sun Pharma's application for expanded indications.
After the Philadelphia Semiconductor Index and Nasdaq plunged, Morgan Stanley called to "get ready to increase positions"
Michael Wilson from Morgan Stanley stated that as the significant correction trajectory in most stock markets over the past few months is about to end, investors should be prepared to increase the risk exposure in their portfolios.
Roadster is just an appetizer? Renowned investor predicts: SpaceX (SPCX.US) may announce the acquisition of Tesla (TSLA.US) within weeks at $420 per share
Gary Black, Managing Director of the Future Fund, recently tweeted a prediction that SpaceX may announce an all-stock acquisition of Tesla within weeks and view the launch of the flying edition Roadster as an opportunity to integrate Elon Musk's companies.
Crypto prices
More
